Cargando…
Ligand-Dependent and Ligand-Independent Effects of Ephrin-B2–EphB4 Signaling in Melanoma Metastatic Spine Disease
Tumor–endothelial cell interactions represent an essential mechanism in spinal metastasis. Ephrin-B2–EphB4 communication induces tumor cell repulsion from the endothelium in metastatic melanoma, reducing spinal bone metastasis formation. To shed further light on the Ephrin-B2–EphB4 signaling mechani...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8347368/ https://www.ncbi.nlm.nih.gov/pubmed/34360793 http://dx.doi.org/10.3390/ijms22158028 |
_version_ | 1783735072437829632 |
---|---|
author | Piffko, Andras Broggini, Thomas Harms, Christoph Adams, Ralf Heinrich Vajkoczy, Peter Czabanka, Marcus |
author_facet | Piffko, Andras Broggini, Thomas Harms, Christoph Adams, Ralf Heinrich Vajkoczy, Peter Czabanka, Marcus |
author_sort | Piffko, Andras |
collection | PubMed |
description | Tumor–endothelial cell interactions represent an essential mechanism in spinal metastasis. Ephrin-B2–EphB4 communication induces tumor cell repulsion from the endothelium in metastatic melanoma, reducing spinal bone metastasis formation. To shed further light on the Ephrin-B2–EphB4 signaling mechanism, we researched the effects of pharmacological EphB4 receptor stimulation and inhibition in a ligand-dependent/independent context. We chose a preventative and a post-diagnostic therapeutic window. EphB4 stimulation during tumor cell seeding led to an increase in spinal metastatic loci and number of disseminated melanoma cells, as well as earlier locomotion deficits in the presence of endothelial Ephrin-B2. In the absence of endothelial Ephrin-B2, reduction of metastatic loci with a later manifestation of locomotion deficits occurred. Thus, EphB4 receptor stimulation affects metastatic dissemination depending on the presence/absence of endothelial Ephrin-B2. After the manifestation of solid metastasis, EphB4 kinase inhibition resulted in significantly earlier manifestation of locomotion deficits in the presence of the ligand. No post-diagnostic treatment effect was found in the absence of endothelial Ephrin-B2. For solid metastasis treatment, EphB4 kinase inhibition induced prometastatic effects in the presence of endothelial Ephrin-B2. In the absence of endothelial Ephrin-B2, both therapies showed no effect on the growth of solid metastasis. |
format | Online Article Text |
id | pubmed-8347368 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-83473682021-08-08 Ligand-Dependent and Ligand-Independent Effects of Ephrin-B2–EphB4 Signaling in Melanoma Metastatic Spine Disease Piffko, Andras Broggini, Thomas Harms, Christoph Adams, Ralf Heinrich Vajkoczy, Peter Czabanka, Marcus Int J Mol Sci Article Tumor–endothelial cell interactions represent an essential mechanism in spinal metastasis. Ephrin-B2–EphB4 communication induces tumor cell repulsion from the endothelium in metastatic melanoma, reducing spinal bone metastasis formation. To shed further light on the Ephrin-B2–EphB4 signaling mechanism, we researched the effects of pharmacological EphB4 receptor stimulation and inhibition in a ligand-dependent/independent context. We chose a preventative and a post-diagnostic therapeutic window. EphB4 stimulation during tumor cell seeding led to an increase in spinal metastatic loci and number of disseminated melanoma cells, as well as earlier locomotion deficits in the presence of endothelial Ephrin-B2. In the absence of endothelial Ephrin-B2, reduction of metastatic loci with a later manifestation of locomotion deficits occurred. Thus, EphB4 receptor stimulation affects metastatic dissemination depending on the presence/absence of endothelial Ephrin-B2. After the manifestation of solid metastasis, EphB4 kinase inhibition resulted in significantly earlier manifestation of locomotion deficits in the presence of the ligand. No post-diagnostic treatment effect was found in the absence of endothelial Ephrin-B2. For solid metastasis treatment, EphB4 kinase inhibition induced prometastatic effects in the presence of endothelial Ephrin-B2. In the absence of endothelial Ephrin-B2, both therapies showed no effect on the growth of solid metastasis. MDPI 2021-07-27 /pmc/articles/PMC8347368/ /pubmed/34360793 http://dx.doi.org/10.3390/ijms22158028 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Piffko, Andras Broggini, Thomas Harms, Christoph Adams, Ralf Heinrich Vajkoczy, Peter Czabanka, Marcus Ligand-Dependent and Ligand-Independent Effects of Ephrin-B2–EphB4 Signaling in Melanoma Metastatic Spine Disease |
title | Ligand-Dependent and Ligand-Independent Effects of Ephrin-B2–EphB4 Signaling in Melanoma Metastatic Spine Disease |
title_full | Ligand-Dependent and Ligand-Independent Effects of Ephrin-B2–EphB4 Signaling in Melanoma Metastatic Spine Disease |
title_fullStr | Ligand-Dependent and Ligand-Independent Effects of Ephrin-B2–EphB4 Signaling in Melanoma Metastatic Spine Disease |
title_full_unstemmed | Ligand-Dependent and Ligand-Independent Effects of Ephrin-B2–EphB4 Signaling in Melanoma Metastatic Spine Disease |
title_short | Ligand-Dependent and Ligand-Independent Effects of Ephrin-B2–EphB4 Signaling in Melanoma Metastatic Spine Disease |
title_sort | ligand-dependent and ligand-independent effects of ephrin-b2–ephb4 signaling in melanoma metastatic spine disease |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8347368/ https://www.ncbi.nlm.nih.gov/pubmed/34360793 http://dx.doi.org/10.3390/ijms22158028 |
work_keys_str_mv | AT piffkoandras liganddependentandligandindependenteffectsofephrinb2ephb4signalinginmelanomametastaticspinedisease AT brogginithomas liganddependentandligandindependenteffectsofephrinb2ephb4signalinginmelanomametastaticspinedisease AT harmschristoph liganddependentandligandindependenteffectsofephrinb2ephb4signalinginmelanomametastaticspinedisease AT adamsralfheinrich liganddependentandligandindependenteffectsofephrinb2ephb4signalinginmelanomametastaticspinedisease AT vajkoczypeter liganddependentandligandindependenteffectsofephrinb2ephb4signalinginmelanomametastaticspinedisease AT czabankamarcus liganddependentandligandindependenteffectsofephrinb2ephb4signalinginmelanomametastaticspinedisease |